Senior Director AI-Driven Commercial IT

Initial Therapeutics, Inc.; Indianapolis (IN); On-site; USD 158,000 - 231,000; Full time

Job summary

Lilly seeks an Information Technology commercial pharma and AI leader to steer an AI-enabled portfolio at a pivotal moment in digital transformation. You will partner with U.S.

commercial, data/AI, analytics, and engineering teams to define KPIs, drive delivery, and shape AI strategy with a bias for speed and value creation. The role demands executive-level communication, thought leadership in AI, and a proven track record in translating strategy into technology roadmaps that deliver measurable

Qualifications

• Proven AI leadership and product innovation experience.
• Ability to translate business strategy into technology roadmaps with measurable outcomes.
• Strong cross-functional collaboration across commercial, analytics, and engineering teams.
• Experience shaping AI-enabled business strategy in pharma or similar industries.

Responsibilities

• Define and drive the AI-enabled portfolio strategy for the assigned business unit.
• Translate strategic priorities into actionable roadmaps and deliver high-quality results.
• Collaborate with commercial, Data & Analytics, and Engineering teams to set KPIs and deliver value.
• Champion a unified product vision across brands, therapeutic areas, and customer segments.

Skills

AI leadership

Roadmap planning

Stakeholder management

Data storytelling

Education

Bachelor's degree in CS/CE or related

Masters preferred

Job description

Lilly seeks an Information Technology commercial pharma and AI leader to steer an AI-enabled portfolio at a pivotal moment in digital transformation. You will partner with U.S.

commercial, data/AI, analytics, and engineering teams to define KPIs, drive delivery, and shape AI strategy with a bias for speed and value creation. The role demands executive-level communication, thought leadership in AI, and a proven track record in translating strategy into technology roadmaps that deliver measurable